Sumitomo Mitsui Trust Holdings, Inc. Guardant Health, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $156 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 2,030,638 shares of GH stock, worth $137 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,030,638
Previous 1,357,227
49.62%
Holding current value
$137 Million
Previous $57.8 Million
82.77%
% of portfolio
0.07%
Previous 0.04%
Shares
21 transactions
Others Institutions Holding GH
# of Institutions
417Shares Held
126MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$821 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$758 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$336 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$325 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$287 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $6.9B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...